On August 28, the City of Yokohama participated in the BIOCOM Devicefest & Digital Health Conference, a one-day event which took place within the conference area of the beautiful Westin Carlsbad Resort in southern California. The event was hosted by BIOCOM, California’s leading support organization for the life science industry, which the City of Yokohama has held strong ties with for years.
This was the 12th meeting of the annually-held Devicefest Conference, and this year’s theme was “The Product Life Cycle.” Filled with panel discussions, keynote speeches, and networking opportunities, the conference is designed to explore the convergence of digital health and the medical device, with this year’s meeting additionally focused on highlighting the process of creating a product, and exploring that process from creation to reimbursement. The keynote speaker for this year’s event was John Dobak, M.D., CEO of DermTech, who shared insights from his company’s experience in bringing their innovative non-invasive skin genomics platform and product for the early detection of melanoma to the market.
2019 marks the third year since the City of Yokohama and BIOCOM signed an ongoing MOU to work together to grow their regions’ life science clusters, and the 62nd year of sister city relations between Yokohama and San Diego. The City of Yokohama looks forward to continued partnership and cooperation with BIOCOM and San Diego.
Related posts:
Yokohama City shares vision for global collaboration in climate action at GCoM Board meeting
Cold winter gear from Yokohama, Japan arrives in Odesa, Ukraine following attacks disabling city heating and electricity
The World’s largest Medical Technology Trade Fair “COMPAMED” was held in Düsseldorf, Germany, and five Companies from Yokohama exhibited their Technologies
